Why a ‘Most Favored Nation’ Policy Would Hand China the Advantage – and Hurt Patients at Home
by Chrissy Buteas, President and Chief Executive OfficerHealthCare Institute of New Jersey (HINJ) March 4, 2026 ― When a patient learns of a life-altering diagnosis – an aggressive blood cancer, a progressive autoimmune disorder, or a rare disease – the first question they’ll ask is: Is there a new treatment that can help me? Increasingly, […]
Buteas Pitches State: N.J. Is Where Science, Manufacturing, Talent, and Patients Come Together at Scale (BINJE.com)
HINJ CEO showcases sector during keynote at Synergistix global life science collaboration conference in Florida By Tom Bergeron March 3, 2026 Chrissy Buteas got straight to the point. “If you want to see what it looks like when science, manufacturing, talent, and patients all come together at scale — look at New Jersey,” she said. […]
HealthCare Institute of New Jersey Statement on the State of the Union’s “Most Favored Nation” Drug Pricing Proposal
Trenton, February 25, 2026 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ – www.hinj.org), released the following statement concerning the “Most Favored Nation” drug pricing proposal referenced in last night’s State of the Union address: “New Jersey and America lead the world in drug discovery and curing […]
Healthcare Institute of New Jersey Statement on State Senate Confirmation of Dr. Stephen Cha as Department of Human Services Commissioner
Trenton, February 24, 2026 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ – www.hinj.org), released the following statement concerning the New Jersey State Senate’s confirmation of Dr. Stephen Cha as Commissioner of the Department of Human Services: “New Jersey’s life sciences community congratulates Dr. Cha on his […]
Op-Ed: Other States are Recruiting Away New Jersey’s Industry. Here’s How We Stop Them.
by Chrissy Buteas, President and Chief Executive OfficerHealthCare Institute of New Jersey (HINJ) For over one hundred and fifty years, New Jersey has been known as the “Medicine Chest of the World.” Our state’s economy revolves around its innovation sector, which has been saving lives globally for generations. Life sciences companies in New Jersey contribute […]
HealthCare Institute of New Jersey Statement on the Sherrill Administration’s Economic Development and Innovation Report
Trenton, February 18, 2026 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ – www.hinj.org), released the following statement concerning the release of the Sherrill Administration’s Economic Development and Innovation Report: “We are excited to work with Governor Sherrill and her team to protect New Jersey’s status as […]
Op-Ed: The Secret Middleman Driving Up Prescription Costs – and How We Fix It
By Chrissy Buteas, President and Chief Executive Officer, HealthCare Institute of New Jersey (HINJ) February 9, 2026 ― Every month, a grandmother in Bridgewater heads to the local pharmacy to pick up her heart medication. But one month, she’s shocked to find that her co‑pay has tripled from $40 to $120. Nothing about the drug […]
HealthCare Institute of New Jersey Statement on Federal Prescription Medicine Direct-Purchase Program
Trenton, February 5, 2026 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ – www.hinj.org), released the following statement concerning the federal government’s newly-announced direct-purchase program for prescription medicines: “Many biopharma companies have long offered direct-purchase programs to help patients when middlemen and insurers make it difficult to […]
HealthCare Institute of New Jersey Statement on the Passage of Federal PBM Reforms
Trenton, February 3, 2026 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ – www.hinj.org), released the following statement concerning Congressional passage of federal reforms to pharmacy benefit manager (PBM) practices: “We thank our federal representatives for their tireless work to lower healthcare costs. Today’s passage of this […]
HealthCare Institute of New Jersey Statement on Governor Sherrill’s Permitting Executive Order #5
Trenton, January 21, 2026 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning New Jersey Governor Mikie Sherrill’s Executive Order #5 regarding permitting: “New Jersey today took a significant step in strengthening our innovation economy as Governor Mikie Sherrill signed Executive Order #5, reinforcing […]